NNPA NEWSWIRE — In early 2022, Ozempic rose to fame when celebrities who do not suffer from diabetes began publicizing the drugs’ ability to assist in...
NNPA NEWSWIRE — “Obesity is a complex chronic disease and a public health epidemic that costs our nation billions of dollars. As an Emergency Physician, I...
BLACK VOICE NEWS — The cost of insulin nearly tripled from 2002 to 2013 and has doubled again since then.
WASHINGTON (AP) — Federal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity. The panel...
Feb 25 (Reuters) – An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co proved as effective in lowering blood sugar as...
[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed...